Global Vaccine CMOs data provides extensive data and analyses of over 150 vaccine-focused contract manufacturing service providers and their manufacturing facilities. It features end-to-end capabilities of small or large-scale manufacturers and provides detailed insights that are available nowhere in the market the goal of assisting market players in advancing their priorities and investments, as well as accessing the competitive landscape across 4 regions- Asia, Europe, North-America, Rest of the World.
It features the worldwide Vaccine CMO’s (Pharmaceutical, Biopharma, Others) capabilities based on various parameters and tracks in-depth data across different stages of manufacturing such as the clinical and commercial scale of productions.
The data is captured around 20 vital metrics including vaccine manufacturer’s name, country, service offerings, manufacturing scale, technology platforms, vaccines manufactured, projects of CMOs, vaccine facility name & location, establishment year, facility size & capacity, annual production, batch size, bioprocessing equipment, bioreactors, expression system, manufacturing process type, regulatory compliance & certifications, sponsors & collaborations, future plans of CMOs and many other parameters. Complete list of parameters is provided in the following section.
The data is underpinned by user-friendly visuals to allow users to filter through within all the parameters to obtain any specific data such as Vaccine CMOs by country, vaccine type, manufacturing scale, regulatory compliance, equipment, service offerings, facility size, expression system, manufacturing process mode among other useful filters.
Outsourcing has become increasingly significant as it offers end-to-end manufacturing solutions and expertise in vaccine manufacturing. North America is seeing the increasing trend of outsourcing for contract manufacturing in the region with highest numbers of CMOs operating across US. Europe has the second highest market for vaccine contract manufacturing with increasing demand for new vaccines and expanding biopharma market. Growing vaccine pipelines and increasing outsourcing of vaccine operations in the APAC region is likely to influence the vaccine CMO market in the coming years.